Rilpivirine
- Product NDC
- 70069-848
- 11-digit product format
- 700690848
- Labeler code
- 70069
- Product ID
- 70069-848_8d833cc1-60b6-4e31-aff3-2958b8f93d1f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rilpivirine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Somerset Therapeutics, LLC
- Application
- ANDA218798
- Marketing category
- ANDA
- Marketing start
- 2026-01-30
- Substance
- RILPIVIRINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rilpivirine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RILPIVIRINE HYDROCHLORIDE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 212WAX8KDD |
| Rxcui | 1102273 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70069-848-30 | Rilpivirine | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70069-848-30 | 70069084830 | 30 TABLET, FILM COATED in 1 BOTTLE (70069-848-30) | 2026-01-30 | No | No | Historical |